Dr Reddys Laboratories RDY
NYSE RDY
$12.63 -0.22 (-1.67%)
As of: Sep 30, 2026 · 9:35 AM EDT

Dr Reddys Laboratories (RDY) Convertible Debt (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Convertible Debt of $73.35 million for the quarter ended Jun 30, 2026, down 5.2% from $77.36 million a year earlier and down 11.2% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Convertible Debt (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories posted Convertible Debt of $80 million, up 11.1% from the prior year.

  • Convertible Debt has a five-year compound annual growth rate of 11.2% (years ended Mar 2021 to Mar 2026).
  • By year, Convertible Debt came in at $72 million in the year ended Mar 31, 2025 (+10.8%), $65 million in the year ended Mar 31, 2024 (-1.5%), $66 million in the year ended Mar 31, 2023 (+17.9%) and $56 million in the year ended Mar 31, 2022 (+19.1%).
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Convertible Debt since the quarter ended Mar 31, 2025.
  • Year over year, Convertible Debt gained in six of the last eight quarters, with growth averaging 9.0%.
  • The high point for year-over-year Convertible Debt in five years was the quarter ended Jun 30, 2022 (growth of 24.5%); the low point was the quarter ended Jun 30, 2026 (a decline of 5.2%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $82.59 million (quarter ended Mar 31, 2026), $74.1 million (quarter ended Dec 31, 2025) and $75.07 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73.35 Mn
Mar 31, 2026 82.59 Mn
Dec 31, 2025 74.10 Mn
Sep 30, 2025 75.07 Mn
Jun 30, 2025 77.36 Mn
Mar 31, 2025 71.23 Mn
Dec 31, 2024 66.02 Mn
Sep 30, 2024 60.90 Mn
Jun 30, 2024 66.32 Mn
Mar 31, 2024 64.82 Mn
Dec 31, 2023 64.05 Mn
Sep 30, 2023 63.38 Mn
Jun 30, 2023 65.62 Mn
Mar 31, 2023 66.35 Mn
Dec 31, 2022 59.67 Mn
Sep 30, 2022 58.83 Mn
Jun 30, 2022 58.71 Mn
Mar 31, 2022 56.63 Mn
Dec 31, 2021 53.49 Mn
Sep 30, 2021 50.53 Mn
API Access

Dr Reddys Laboratories Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=RDY&period=max&api_key=YOUR_API_KEY